RE:Health Canada approves another Abbott testIn data submitted to the FDA from a clinical study conducted by Abbott with several leading U.S. research universities, the BinaxNOW COVID-19 Ag Card demonstrated sensitivity of 97.1% (positive percent agreement) and specificity of 98.5% (negative percent agreement) in patients suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset.
-------------------------------------------------------------------------------------
- So this means that the test misses assymptomatic individuals? If you contract COVID, one to three days is usually no symptoms. Meaning this test will miss those people. You have to be exhibtting symptoms for this to even work.... Correct me if i'm wrong.